{"name":"Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd.","slug":"dongguan-hec-taigen-biopharmaceuticals-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"DAG181","genericName":"DAG181","slug":"dag181","indication":"Non-small cell lung cancer","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"TG-2349","genericName":"TG-2349","slug":"tg-2349","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"DAG181","genericName":"DAG181","slug":"dag181","phase":"phase_3","mechanism":"DAG181 is a humanized monoclonal antibody that targets and blocks PD-L1, enhancing anti-tumor immune responses by releasing the PD-1/PD-L1 checkpoint inhibition.","indications":["Non-small cell lung cancer","Other solid tumors (under investigation in Phase 3)"],"catalyst":""},{"name":"TG-2349","genericName":"TG-2349","slug":"tg-2349","phase":"phase_3","mechanism":"TG-2349 is a small molecule drug that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNWi1jazNVV0tlVGZnOEhERnJNaVQ1UGpjbXAycHVoR091a3o3WmdoUkRPVElJWnZ2SVZBd3RXLTVCR2FDR1JjemRGb21zMVQtaXB3QXRhZkNzVmMzMDBCck9sUjhiOVQ3b0Zoc0x5ZXA3bkR0SWJzc1dteVdhRWlQSnFodVFsdlFBRFJYQ1VNNGJLeEsyZXVVSw?oc=5","date":"2026-04-08","type":"trial","source":"openPR.com","summary":"Hepatitis C Virus Infection Clinical Trial Pipeline Shows - openPR.com","headline":"Hepatitis C Virus Infection Clinical Trial Pipeline Shows","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}